MIG Fonds

KONUX, a European AI scale-up in rail transport and a MIG Fonds portfolio company, launched its modular Data Intelligence Platform, KONUX CoBrix.

MIG Fonds 1 was an early fund specializing in early-stage investments and sustainable growth, highlighting its development and key achievements.

MIG Fonds 3 (MIG GmbH & Co. Fonds 3 KG i.L.) was dissolved on October 5, 2021, with remaining assets transferred to MIG Asset Trust GmbH for potential payouts to former investors.

MIG Fonds 5 targets cutting-edge technologies and strong founder teams, detailing its portfolio, performance, and vision.

Andrea Pfeifer leads AC Immune, researching Alzheimer therapies for over 20 years. She has worked in medicine or pharmaceuticals since childhood, despite her family’s engineering background.

mbiomics, a portfolio company of MIG Fonds 16 and 17, designs microbiome-based live therapeutics for chronic diseases using AI to restore microbial balance.

The Handelsblatt identified four cancer specialists, including MIG Fonds portfolio companies iOmx and SciRhom, as promising German biotech firms.

Michael Motschmann founded MIG Capital nearly 20 years ago, launching the MIG Fonds product. The company has invested in 55 start-ups totaling 750 million euros and distributed 1.1 billion euros to investors, including BioNTech.

Quantum computing gains traction in Germany, with IQM opening a quantum computing center in Munich featuring two processors, expandable to twelve.

GWA Hygiene GmbH acquired Hypros GmbH & Co. KG.

IQM, a leading quantum computer manufacturer and MIG Fonds portfolio company, will provide IQM Garnet quantum processors via Amazon Braket.

The Leibniz Supercomputing Centre launched Q-Exa, combining IQM’s 20-qubit processor with the Super-MUC NG supercomputer.

ASTRA Therapeutics AG, a portfolio company of MIG Fonds 17 and 18, appointed Dr. Fabian Kausche as chairman of the board.

HMW Kapitalanlagen, the exclusive distributor of MIG Fonds, mobilizes capital for sustainable investments and strong returns.

The following pages provide details on individual MIG Fonds and visionary portfolio company investments.

Weekly webinars highlight how MIG Fonds portfolio companies address climate change, sustainable medicine, and circular economy challenges.

MIG Fonds combines expertise with foresight for sustainable investments in high-growth industries.

MIG Fonds invites inquiries about investments, participations, or general information.

MIG Fonds offers bank- and exchange-independent investments in forward-looking technology companies.

The page explains how MIG Fonds handles user data, emphasizing transparency, security, and privacy protection.

MIG Fonds implements digital accessibility to ensure its website is usable for all visitors.

The imprint lists all legally required information about MIG Fonds, including provider details, contact, legal notices, and responsibilities.

The legal notices outline liability, copyright, external links, and other key terms for the MIG Fonds website.